Evaluation in patients with type 2 diabetes mellitus attended by the Municipal Pharmacy of Santa Maria, RS, Brazil: pharmaceutical intervention records

Abstract

Type 2 diabetes mellitus (DM), characterized by hyperglycemia associated with defects in insulin secretion/action, affects a large number of individuals. Adequate glycemic control can reduce the risk of developing complications. However, as it is a silent disease, the time for diagnosis can facilitate the development of other diseases, which leads to the use of other drugs and, consequently, to drug interactions (MI). The objective of this study was to carry out a pharmaceutical intervention in the municipal pharmacy of Santa Maria, aiming at improving the glycemic control of patients with type 2 DM. Questionnaires were used to obtain data about the disease and the medications used by this population. Patients were followed up monthly (for three months). IM were searched in the Drugs database. The results show that most patients are women, over 50 years of age and the disease was diagnosed after 35 years of age. In addition, they have a family history of DM and already manifest some type of complication. The pharmacotherapeutic follow-up and health education services suggested a positive response to DM control in the treated patients. Regarding the most used medications, there were hypoglycemic agents, such as metformin and insulin, in addition to antihypertensives. A total of 323 MI was found, 11 classified as severe. The results confi rmed that pharmaceutical guidance greatly helps the patient to understand the infl uence of adherence to treatment and the inclusion of lifestyle changes in adequate glycemic control.